|Articles|August 31, 2012
Trastuzumab Link to Heart Failure Seen
Advertisement
Treatment with trastuzumab (Herceptin) boosts risk of heart failure or cardiomyopathy in breast cancer survivors, an observational study affirmed.
Women who received trastuzumab alone were 4.12 times more likely (95% CI 2.30 to 7.42) to go into heart failure after accounting for other factors, Erin Aiello Bowles, MPH, of the Group Health Research Institute in Seattle, and colleagues found.
Read the full story:
Source: MedPage Today
Advertisement
Related Content
Advertisement
Advertisement
Trending on AJMC
1
FDA Approves First Oral Carbapenem Antibiotic for Complicated UTIs
2
Fourteen Years of HIV PrEP: How New Innovations Build on Decades of Progress in HIV
3
EHA 2026 Had Something for Everyone, From Pediatric Practitioners to “Myeloma Maniacs”
4
Monoclonal Antibodies Had Varying Efficacy in Treating MG
5